|
|
||||||||
1Department of Physiology and 2Department of Pharmacology, Akdeniz University Faculty of Medicine, Antalya, Turkey 07070; and 3Department of Physiology and Biophysics, Keck School of Medicine, University of Southern California, Los Angeles, California 90033
Submitted 6 June 2003 ; accepted in final form 15 September 2003
The effects of enhanced red blood cell (RBC) aggregation on nitric oxide (NO)-dependent vascular control mechanisms have been investigated in a rat exchange transfusion model. RBC aggregation for cells in native plasma was increased via a novel method using RBCs covalently coated with a 13-kDa poloxamer copolymer (Pluronic F-98); control experiments used RBCs coated with a nonaggregating 8.4-kDa poloxamer (Pluronic F-68). Rats exchange transfused with aggregating RBC suspensions demonstrated significantly enhanced RBC aggregation throughout the 5-day follow-up period, with mean arterial blood pressure increasing gradually over this period. Arterial segments (
300 µm in diameter) were isolated from gracilis muscle on the fifth day and mounted between two glass micropipettes in a special chamber equipped with pressure servo-control system. Dose-dependent dilation by ACh and flow-mediated dilation of arterial segments pressurized to 30 mmHg and preconstricted to 4555% of the original diameter by phenylephrine were significantly blunted in rats with enhanced RBC aggregation. Both responses were totally abolished by nonspecific NO synthase (NOS) inhibitor (N
-nitro-L-arginine methyl ester) treatment of arterial segments, indicating that the responses were NO related. Additionally, expression of endothelial NOS protein was found to be decreased in muscle samples obtained from rats exchanged with aggregating cell suspensions. These results imply that enhanced RBC aggregation results in suppressed expression of NO synthesizing mechanisms, thereby leading to altered vasomotor tonus; the mechanisms involved most likely relate to decreased wall shear stresses due to decreased blood flow and/or increased axial accumulation of RBCs.
flow-mediated dilation; poloxamer coating
This article has been cited by other articles:
![]() |
O. Yalcin, P. Ulker, U. Yavuzer, H. J. Meiselman, and O. K. Baskurt Nitric oxide generation by endothelial cells exposed to shear stress in glass tubes perfused with red blood cell suspensions: role of aggregation Am J Physiol Heart Circ Physiol, May 1, 2008; 294(5): H2098 - H2105. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kim, R. L. Kong, A. S. Popel, M. Intaglietta, and P. C. Johnson Temporal and spatial variations of cell-free layer width in arterioles Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1526 - H1535. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Connes, O. Yalcin, O. Baskurt, J.-F. Brun, and M. Hardeman In health and in a normoxic environment, VO2 max is/is not limited primarily by cardiac output and locomotor muscle blood flow J Appl Physiol, June 1, 2006; 100(6): 2099 - 2099. [Full Text] [PDF] |
||||
![]() |
S. Kim, A. S. Popel, M. Intaglietta, and P. C. Johnson Effect of erythrocyte aggregation at normal human levels on functional capillary density in rat spinotrapezius muscle Am J Physiol Heart Circ Physiol, March 1, 2006; 290(3): H941 - H947. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Yalcin, F. Aydin, P. Ulker, M. Uyuklu, F. Gungor, J. K. Armstrong, H. J. Meiselman, and O. K. Baskurt Effects of red blood cell aggregation on myocardial hematocrit gradient using two approaches to increase aggregation Am J Physiol Heart Circ Physiol, February 1, 2006; 290(2): H765 - H771. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Yalcin, M. Uyuklu, J. K. Armstrong, H. J. Meiselman, and O. K. Baskurt Graded alterations of RBC aggregation influence in vivo blood flow resistance Am J Physiol Heart Circ Physiol, December 1, 2004; 287(6): H2644 - H2650. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Levin, R. Gamzu, Y. Hasson, J.B. Lessing, A. Amit, I. Shapira, S. Berliner, and B. Almog Increased erythrocyte aggregation in ovarian hyperstimulation syndrome: a possible contributing factor in the pathophysiology of this disease Hum. Reprod., May 1, 2004; 19(5): 1076 - 1080. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |